Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.
Also called NCT01666041
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT01666041
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01666041. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- placebo
- Intervention (Drug)
- fenofibrate/omega
- Intervention (Drug)
- fenofibrate
- Lead sponsor
- Gachon University Gil Medical Center
Record details
- Record id
cardio:ct-nct01666041- Content hash
0e6098dae656190206073ad73194a7a20de69b58b2869411b9d390fa9b44e326